SCHEMBL6591699

SCHEMBL6591699

Cc1c(-c2cc3cc(C(=O)N(C)c4ccccc4)ccc3o2)oc(=O)c(C)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.46
PLAU P00749 2/20 0.44
MAPT P10636 2/20 0.37
HTT P42858 1/20 0.37
KDM4E B2RXH2 3/20 0.36
KMT2A Q03164 1/20 0.36
ATM Q13315 1/20 0.36
F2 P00734 1/20 0.35
F10 P00742 1/20 0.35
PLG P00747 1/20 0.35
PLAT P00750 1/20 0.35
PRSS1 P07477 1/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35
CASP3 P42574 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6591627 0.90 KDM4E (0.38) MAOBPLAUKDM4EKMT2ATP53
SCHEMBL6592236 0.90 MAOB (0.41) MAOBMAPTKDM4EKMT2ANR1H3
SCHEMBL6591785 0.88 TRPV1 (0.40) MAOBPLAUMAPTKDM4EKMT2A
SCHEMBL6589647 0.85 LIPE (0.36) MAPTKMT2ATP53
SCHEMBL6594210 0.85 ALDH1A1 (0.47) HTTKMT2ATSHRRAB9ASMN1; SMN2
SCHEMBL6595885 0.83 TP53 (0.46) MAOBPLAUMAPTKDM4EF2
SCHEMBL6591256 0.82 LMNA (0.50) MAPTKDM4EKMT2AATMNPC1
SCHEMBL6593781 0.81 MLYCD (0.41) MAOBMAPTHTTKDM4EKMT2A
SCHEMBL6593647 0.81 MEN1 (0.32) MAPTKDM4EKMT2AATMNPC1
SCHEMBL6592675 0.79 PDK1 (0.40) KDM4EKMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP disclosed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US disclosed
US-6589984-B1 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as TEIJIN LIMITED (JP) 2003-07-08 US disclosed
CN-1299359-A Benzofurylpyrone derivatives TEIJIN LTD (JP) 2001-06-13 CN disclosed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186976-A1 Benzofurylpyrone derivatives PLIN5, ACSL5, PLIN1 MAOB 3367/4885PLAU 3686/4885MAPT 3955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.